Author

Filippo Acconcia

Roma Tre UniversityORCID 0000-0002-4651-2509Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Fabrizio BianchiiD· 1 shared Manuela CipollettiiD· 1 shared Sara PescatoriiD· 1 shared Stefania BartoloniiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Fabrizio BianchiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedApr 8, 2024

Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer

Stefania Bartoloni, Sara Pescatori, Fabrizio Bianchi…·Filippo Acconcia

This study identifies ALK and MELK inhibition as potential targets for specific breast cancer subtypes by showing their impact on ER stability and proliferation.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky